BMY
$59.71
Bristol-Myers Squibb
$.22
.37%
BMY
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $1.48
Revenue:  $10.37 Bil
Thursday
Nov 5
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BMY reports earnings?
Beat
Meet
Miss

Where is BMY's stock price going from here?
Up
Flat
Down
Stock chart of BMY
Analysts
Summary of analysts' recommendations for BMY
Score
Grade
Pivots
Resistance
$61.54
$60.88
$60.29

$59.63

Support
$59.04
$58.38
$57.79
Tweet
Growth
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Peers
InterCeptBioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsZoetisJohnson & JohnsonUltragenyx PharmaceuticalMerck & Co.CatalentMylan